APA

Coughlin C. M., Salhany K. E., Gee M. S., LaTemple D. C., Kotenko S., Ma X., Gri G., Wysocka M., Kim J. E., Liu L., Liao F., Farber J. M., Pestka S., Trinchieri G. & Lee W. M. (19980901). Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis. : Immunity.

Chicago

Coughlin C M, Salhany K E, Gee M S, LaTemple D C, Kotenko S, Ma X, Gri G, Wysocka M, Kim J E, Liu L, Liao F, Farber J M, Pestka S, Trinchieri G and Lee W M. 19980901. Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis. : Immunity.

Harvard

Coughlin C. M., Salhany K. E., Gee M. S., LaTemple D. C., Kotenko S., Ma X., Gri G., Wysocka M., Kim J. E., Liu L., Liao F., Farber J. M., Pestka S., Trinchieri G. and Lee W. M. (19980901). Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis. : Immunity.

MLA

Coughlin C M, Salhany K E, Gee M S, LaTemple D C, Kotenko S, Ma X, Gri G, Wysocka M, Kim J E, Liu L, Liao F, Farber J M, Pestka S, Trinchieri G and Lee W M. Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis. : Immunity. 19980901.